Beginning with clear descriptions of the pathogenesis of osteoporosis and secondary osteoporosis, and the development of fractures, the book emphasizes the importance of prevention as well as treatment of this disease. There is a chapter on the beneficial effects of good nutrition and exercise on ...
(5) the joint(s) studied; (6) the cell type studied; (7) the drug studied; (8) drug route of administration, dosage, frequency, and treatment length; (9) methods of outcome assessment before and after treatment; (10) results/outcomes; and (11) association between treatment and results...
Initial treatment selection should also consider the probability that a BMD treatment target can be attained within a reasonable period of time and the differential magnitude of fracture risk reduction and BMD impact with osteoanabolic versus antiresorptive therapy. This position statement of the ASBMR/...
All patients underwent BMD measurement of the proximal femur of the contralateral side (i.e., nonsurgical side) before or after surgery using DXA to select the appropriate surgical implant and initiate osteoporosis treatment when diagnosed. Hologic’s DXA was used in both institutions (A: Horizon ...
Inclusion criteria and exclusion criteria for patients with primary osteoporosis and healthy volunteers were according to the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2017). Criteria for inclusion: (1) elderly PMO patients aged ≥ 65 years; (2) outpatients and ...
Physical activity as a modifiable lifestyle intervention has been shown to have a possible role in the prevention and treatment of low BMD [18]. Also, researches suggested in adolescent girls with high levels of physical activity, eating UPF is more detrimental to bone health [19]. However, ...
Denosumab versus romosozumab for postmenopausal osteoporosis treatment Article Open access 03 June 2021 Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study Article Open access 01 October 2024 Denosumab for dialysis patients with osteoporosis: ...
through inhibition of the nuclear factor kappa-B signaling pathway, thereby normalizing the osteoporotic microenvironment. This collaborative therapeutic strategy that focuses on improving bone microenvironment and promoting osteogenesis provides new insight for the treatment of metabolic diseases such as ...
particularly to investigate the effect of pharmacological intervention on fracture prevention. For this reason, there are currently no evidence-based guidelines for the treatment of affected individuals with early-onset osteoporosis. Instead, preventive measures and individualised treatment approaches are genera...
Hansen PJ, Knitschke M, Draenert FG et al (2013) Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment-a grossly underestimated risk? Clin Oral Investig 17:1829–1837. https://doi.org/10.1007/s00784-012-0873-3 Article...